Abivax (ABVX) Income towards Parent Company: 2022-2025
Historic Income towards Parent Company for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$54.8 million.
- Abivax's Income towards Parent Company fell 31.26% to -$54.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$151.6 million, marking a year-over-year decrease of 71.69%. This contributed to the annual value of -$188.3 million for FY2024, which is 18.48% down from last year.
- Latest data reveals that Abivax reported Income towards Parent Company of -$54.8 million as of Q2 2025, which was up 0.52% from -$55.1 million recorded in Q1 2025.
- In the past 5 years, Abivax's Income towards Parent Company registered a high of -$66.11 during Q4 2022, and its lowest value of -$55.1 million during Q1 2025.
- Its 3-year average for Income towards Parent Company is -$33.0 million, with a median of -$44.2 million in 2024.
- Data for Abivax's Income towards Parent Company shows a maximum YoY tumbled of 107.34% (in 2023) over the last 5 years.
- Over the past 4 years, Abivax's Income towards Parent Company (Quarterly) stood at -$66.11 in 2022, then slumped by 107.34% to -$137.07 in 2023, then slumped by 34.79% to -$184.76 in 2024, then crashed by 31.26% to -$54.8 million in 2025.
- Its Income towards Parent Company was -$54.8 million in Q2 2025, compared to -$55.1 million in Q1 2025 and -$184.76 in Q4 2024.